FDA Approves Xiaflex for Debilitating Hand Condition The U.S. Food
FDA Approves Xiaflex for Debilitating Hand Condition
The U.S. Food and Drug Administration today approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person s ability to straighten and properly use their fingers.